Accelevir’s patented IPDA™ (Intact Proviral DNA Assay) has been deployed under our highly controlled Quality Management System to support over 100 clinical studies which encompass ~ 10,000 diverse samples. This depth of experience in clinical sample handling has enabled the company to adopt best practices for assay robustness, reproducibility, and data analysis. The Accelevir workflow adopts GLP-like practices across all workflows that impact the IPDA™ data quality, which is informed by stringent SOPs and a robust Quality Management System. The Company has been independently audited by Customers and Partners.
Assays are performed in a CLIA-certified laboratory whereby the IPDA™ output is highly controlled within the end-end workflow. Accelevir’s deep expertise in cellular processing, handling of viable PBMC’s and further isolation of cellular subfractions are considered critical aspects for assay reproducibility. The Virology workflow is supported by highly trained personnel ensuring the preservation of cell quality and downstream assay results. Additionally, Accelevir offers consultative support and detailed data analysis to ensure the best outcomes for their customers.
Get Started with Accelevir’s IPDA™ Services
Accelerate your HIV research with Accelevir’s high-quality IPDA™ HIV-1 assay services. Contact us to design a custom assay for your project.
- IPDA™ HIV-1
- IPDA™ SIV
- IPDA™ SHIV
- Total HIV-1 DNA qPCR
- HIV-1 Cell-associated RNA PCR
- QVOA (Quantitative Viral Outgrowth Assay) HIV-1
- Bulk Outgrowth HIV-1
- SCA (Single Copy Assay) HIV-1
- HIV-1 Viral Load **
- SalivaDirect™ SARS-CoV-2 **
- TaqPath COVID-19 Multiplex **